MedRhythms, a Portland-based company that combines sensors, neuroscience and music to help people recover from neurologic injury or disease, announced Friday it raised $5 million in an oversubscribed Series A Financing round. The company stated in a news release that it intended to raise $4 million but due to substantial interest it raised the offering to $5.3 million. By the time of Friday’s announcement, it had raised $5 million. This investment will allow MedRhythms to develop and launch a patent-pending digital therapeutics platform that focuses on building evidence-based, FDA-approved, prescription products for people with neurologic injuries and diseases to improve and measure walking. While the first product on the platform focuses on the post-stroke population, the pipeline includes products for Parkinson’s disease, multiple sclerosis, aging-In-place and traumatic brain injury. Read more here.
Related Posts
Maine’s startup ‘mojo’ highlighted in national ranking
As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...
Maine CDC Director Nirav Shah to join U.S. CDC leadership
Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...
$5.6M in state funding to support Maine startups, entrepreneurs
Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...